Commission Implementing Regulation (EU) 2021/52 of 22 January 2021 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances benfluralin, dimoxystrobin, fluazinam, flutolanil, mecoprop-P, mepiquat, metiram, oxamyl and pyraclostrobin
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD) Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XV Dangerous Substances
Joint committee decision (JCD)
239/2021 In force in the EEA
Yes Legal documents
Commission Implementing Regulation (EU) 2021/52 of 22 January 2021 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances benfluralin, dimoxystrobin, fluazinam, flutolanil, mecoprop-P, mepiquat, metiram, oxamyl and pyraclostrobin
Framkvæmdarreglugerð framkvæmdastjórnarinnar (ESB) 2021/52 frá 22. janúar 2021 um breytingu á framkvæmdarreglugerð (ESB) nr. 540/2011 að því er varðar framlengingu á samþykkistímabilunum fyrir virku efnin benflúralín, dímoxýstróbín, flúasínam, flútólaníl, mekópróp-P, mepíkvat, metíram, oxamýl og pýraklóstróbín
Durchführungsverordnung (EU) 2021/52 der Kommission vom 22. Januar 2021 zur Änderung der Durchführungsverordnung (EU) Nr. 540/2011 hinsichtlich der Verlängerung der Laufzeit der Genehmigung für die Wirkstoffe Benfluralin, Dimoxystrobin, Fluazinam, Flutolanil, Mecoprop-P, Mepiquat, Metiram, Oxamyl und Pyraclostrobin
Kommisjonens gjennomføringsforordning (EU) 2021/52 av 22. januar 2021 om endring av gjennomføringsforordning (EU) nr. 540/2011 med hensyn til forlengelse av godkjenningsperioden for de aktive stoffene benfluralin, dimoksystrobin, fluazinam, flutolanil, mekoprop-P, mepikvat, metiram, oksamyl og pyraklostrobin
History
25.09.2021
Adopted JCD confirmed entry into force date
25.09.2021
Compliance date in the EEA
24.09.2021
Adoption of Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement
07.07.2021
Draft Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement sent to Commission
22.01.2021
Adoption date in the EU
14.02.2021
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.